Author:
Liu Li,Ye Qing,Lu Maggie,Chen Shih-Ta,Tseng Hsiang-Wen,Lo Ya-Chin,Ho Chien
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Cancer nanomedicine: progress, challenges and opportunities. Nature reviews. Cancer 17, 20–37 (2017).
2. Hare, J. I. et al. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Advanced drug delivery reviews 108, 25–38 (2017).
3. Min, Y., Caster, J. M., Eblan, M. J. & Wang, A. Z. Clinical Translation of Nanomedicine. Chemical Reviews 115, 11147–11190 (2015).
4. Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46, 6387–6392 (1986).
5. Gerlowski, L. E. & Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvascular Research 31, 288–305 (1986).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献